Get started
Author

Alison Portnoy

Observed institution: GlaxoSmithKline (United States)
OpenAlex ID: A5078397196
Challenges of antibacterial discovery revisited
2010 · Michael N. Gwynn, Alison Portnoy, et al. · Annals of the New York Academy of Sciences · 193
A phase IIa study of afuresertib, an oral pan‐AKT inhibitor, in patients with Langerhans cell histiocytosis
2016 · Robert J. Arceci, Carl E. Allen, et al. · Pediatric Blood & Cancer · 24
Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
2013 · Alison Portnoy, Sanjay Kumar, et al. · Frontiers in Pharmacology · 14
PDF
Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis
2013 · Robert J. Arceci, Carl E. Allen, et al. · Blood · 10
No let up in the search for novel antibiotics
2009 · David J Payne, Alison Portnoy, et al. · Expert Review of Anti-infective Therapy
PDF
Always Obtain a Rectal Temperature to Detect Febrile Illness
2002 · Alison Portnoy · Emergency Medicine News
Works count: 7
Citation count: 241
H-index: 4
I10-index: 4
Year
Topic
Type